share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56

DA Davidson对Usana Health Sciences保持中立,将目标价提高至56美元
Benzinga ·  2023/04/26 22:12

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $52.5 to $56.

DA Davidson分析师琳达·博尔顿·韦瑟维持Usana Health Sciences(纽约证券交易所代码:USNA)的中性,并将目标股价从52.5美元上调至56美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发